This Article Full Text Full Text (PDF) All Versions of this Article: 37/1/231    most recent 01.STR.0000195133.98378.4bv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Achrol, A. S. Search for Related Content PubMed PubMed Citation Articles by Achrol, A. S. Related Collections Acute Cerebral Hemorrhage Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage

(Stroke. 2006;37:231.)
© 2006 American Heart Association, Inc.

Research Reports

Tumor Necrosis Factor-–238G>A Promoter Polymorphism Is Associated With Increased Risk of New Hemorrhage in the Natural Course of Patients With Brain Arteriovenous Malformations

Achal S. Achrol, BS; Ludmila Pawlikowska, PhD; Charles E. McCulloch, PhD; K. Y. Trudy Poon, MS; Connie Ha, BS; Jonathan G. Zaroff, MD; S. Claiborne Johnston, MD, PhD; Chanhung Lee, MD, PhD; Michael T. Lawton, MD; Stephen Sidney, MD, MS; Douglas A. Marchuk, PhD; Pui-Yan Kwok, MD, PhD; William L. Young, MD for the UCSF BAVM Study Project

From the Departments of Anesthesia and Perioperative Care and Center for Cerebrovascular Research (A.S.A., K.Y.P., C.L., W.L.Y.), Cardiovascular Research Institute (L.P., C.H., P.Y.K.), Departments of Epidemiology and Biostatistics (C.E.M., S.C.J.), Neurology (S.C.J., W.L.Y.), Medicine (J.G.Z.), Neurological Surgery (M.T.L., W.L.Y.), University of California, San Francisco, California; Division of Research, Kaiser-Permanente Medical Care Program, Oakland, Calif (S.S.); and the Department of Genetics, Duke University Medical Center, Durham, NC (D.A.M.).

Correspondence to William L. Young, MD, UCSF, 1001 Potrero Ave, Room 3C-38, San Francisco, CA 94110. E-mail ccr{at}anesthesia.ucsf.edu

Background and Purpose— Identification of single-nucleotide polymorphisms (SNPs) associated with increased risk of new intracranial hemorrhage (ICH) after brain arteriovenous malformation (BAVM) diagnosis would facilitate risk stratification and identify potential targets for therapeutic intervention.

Methods— Patients with BAVM were longitudinally followed. Primary outcome was new ICH after diagnosis; censoring events were last follow-up or any BAVM treatment. We genotyped 4 promoter SNPs in 2 inflammatory cytokine genes: interleukin-6 (IL-6–174G>C; IL-6–572G>C) and tumor necrosis factor- (TNF-–238G>A; TNF-–308G>A). Association of genotype with risk of new ICH was screened using ²; SNPs associated with new ICH were further characterized using Cox proportional hazards.

Results— We genotyped 280 patients (50% female; 59% white, mean±SD age at diagnosis 37±17 years; 40% presenting with ICH). TNF-–238G>A was associated with increased risk of new ICH after diagnosis (²; P=0.003). After adjusting for age, race/ethnicity, and clinical presentation, the risk of new ICH was increased for patients with TNF-–238 AG genotype (hazard ratio, 4.01; P=0.015). No other SNP was found to be associated with new ICH.

Conclusion— A TNF- SNP was associated with increased risk of new ICH in the natural course of BAVMs. The role of inflammatory cytokines in the pathogenesis of BAVM hemorrhage merits further study.

Key Words: cerebral hemorrhage • genetics • vascular malformations

This article has been cited by other articles:

				J van Beijnum, H B van der Worp, H M Schippers, O van Nieuwenhuizen, L J Kappelle, G J E Rinkel, J W B. van der Sprenkel, and C J M Klijn Familial occurrence of brain arteriovenous malformations: a systematic review J. Neurol. Neurosurg. Psychiatry, November 1, 2007; 78(11): 1213 - 1217. [Abstract] [Full Text] [PDF]